Newsfeeds Archive - Page 5 of 8

2 minute read

Editas Medicine Receives FDA Orphan Drug Designation For EDIT-301 For The Treatment Of Sickle Cell Disease

April 27, 9:22 AM

Editas Medicine, Inc. (NASDAQ:EDIT), a clinical stage genome editing company, today announced that the U.S. Food and Drug Administration (FDA) granted Orphan Drug Designation to EDIT-301, an investigational, gene

EDIT

4 minute read

Why Satsuma Pharmaceuticals Shares Are Trading Higher By 94%? Here Are Other Stocks Moving In Monday’s Mid-Day Session

By Lisa Levin

April 17, 1:27 PM

Gainers ContraFect Corporation (NASDAQ: CFRX) shares surged 213% to $2.82.

ALLK

4 minute read

Why ViewRay Shares Are Trading Lower By 32%? Here Are Other Stocks Moving In Thursday’s Mid-Day Session

By Lisa Levin

April 13, 12:24 PM

Gainers CXApp Inc. (NASDAQ: CXAI) jumped 105% to $3.28 after climbing over 20% on Wednesday.

AMST

2 minute read

Consolidated Communications, CRISPR Therapeutics And Other Big Stocks Moving Higher On Thursday

By Lisa Levin

April 13, 10:38 AM

U.S. stocks traded higher, with the Dow Jones gaining over 100 points on Thursday. Here are some big stocks recording gains in today’s session.

ALLO

8 minute read

Options

Stocks That Hit 52-Week Lows On Monday

By Benzinga Insights

April 10, 1:48 PM

Monday's session saw 114 companies set new 52-week lows.

ADTN

15 minute read

Options

Stocks That Hit 52-Week Lows On Wednesday

By Benzinga Insights

April 5, 2:28 PM

On Wednesday, 220 stocks hit new 52-week lows.

ABCB

7 minute read

Options

Stocks That Hit 52-Week Lows On Tuesday

By Benzinga Insights

March 28, 1:43 PM

During Tuesday, 95 stocks hit new 52-week lows.

AADI

1 minute read

Editas Medicine Q4 EPS $(0.88) Misses $(0.80) Estimate, Sales $6.54M Beat $3.26M Estimate

By Benzinga Newsdesk

February 22, 7:16 AM

Editas Medicine (NASDAQ:EDIT) reported quarterly losses of $(0.88) per share which missed the analyst consensus estimate of $(0.80) by 10 percent. This is a 44.26 percent decrease over losses of $(0.61) per share from

EDIT